Cao Ling-Xiao, Wang Gang, Guo Qi-Hao, Zhang Wei, Bak Thomas, Huang Yue
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Healthcare (Basel). 2022 Oct 17;10(10):2052. doi: 10.3390/healthcare10102052.
Addenbrooke's cognitive examination (ACE) is a cognitive screening tool that has developed through three stages: ACE, ACE-Revised (ACE-R), and ACE-Ⅲ. In addition, mini-Addenbrooke's Cognitive Examination (M-ACE) and ACE mobile are the additional versions that is derived from ACE-III. ACE and its related versions show better performance than Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) in detecting mild cognitive impairment in different neurological disorders. It has been translated into numerous languages, including Chinese. Through reviewing the history, validity, and comparison with other cognitive tests of Chinese versions of ACE, it aims to facilitate the clinical and scientific use, further development, improvement, and validation of Chinese versions of ACE in various neurological disorders and ultimately promote early identification and management of cognitive impairment in China.
剑桥认知功能量表(ACE)是一种认知筛查工具,历经三个阶段发展而来:ACE、修订版剑桥认知功能量表(ACE-R)和剑桥认知功能量表第三版(ACE-Ⅲ)。此外,简易剑桥认知功能量表(M-ACE)和ACE移动版是源自ACE-Ⅲ的衍生版本。在检测不同神经疾病中的轻度认知障碍方面,ACE及其相关版本比简易精神状态检查表(MMSE)和蒙特利尔认知评估量表(MoCA)表现更佳。它已被翻译成多种语言,包括中文。通过回顾中文版ACE的历史、效度以及与其他认知测试的比较,旨在促进中文版ACE在各种神经疾病中的临床和科学应用、进一步发展、改进及验证,最终推动中国认知障碍的早期识别与管理。